Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „both“
Suchtreffer
Begriffe & Kennungen
Clopidogrel TAD · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.5 · Rifampicin strongly induces CYP2C19, resulting in both an increased level of clopidogrel active metabolite and
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · Rifampicin strongly induces CYP2C19, resulting in both an increased level of clopidogrel active metabolite and
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · 9 In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both g
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.5 · Rifampicin strongly induces CYP2C19, resulting in both an increased level of clopidogrel active metabolite and
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · 9 In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both g
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Rifampicin strongly induces CYP2C19, resulting in both an increased level of clopidogrel active metabolite and
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel ratiopharm · 4.5 · Rifampicin strongly induces CYP2C19, resulting in both an increased level of clopidogrel active metabolite and
Eintrag öffnenClopidogrel ratiopharm · 4.8 · 9 In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both g
Eintrag öffnenClopidogrel ratiopharm · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.3 · Due to the presence of both components of the medicinal product, Clopidogrel/Acetylsalicylic acid Zentiva is c
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in the post-marketing experi
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenCombivir · 4.8 · The available data from both placebo-controlled and open-label studies indicate that the incidence of nausea a
Eintrag öffnen